Default Mode Network Modulation by Psychedelics: A Systematic Review

Gattuso, James J, Perkins, Daniel, Ruffell, Simon, Lawrence, Andrew J, Hoyer, Daniel, Jacobson, Laura H, Timmermann, Christopher, Castle, David +6 more·2023·International Journal of Neuropsychopharmacology
DOI 10.1093/ijnp/pyac074

Cited by (255)

Items 101–200 of 255

  1. LSD: Mechanisms and relevance to the treatment of depression
    Amel Bouloufa, Sarah Delcourte, Thomas Delannay, Renaud Rovera, Thorsten Lau, Lionel Moulédous, Ouria Dkhissi‐Benyahya, Bruno Pierre Guiard, Nasser Haddjeri · 2025 · Neuroscience & Biobehavioral Reviews
  2. A narrative exploration of psilocybin’s potential in mental health
    Huitae Min, Soon-Young Park, Jisu Park, Seongsu Na, Hoe-Suk Lee, Taejung Kim, Jungyeob Ham, Young-Tae Park · 2024 · Frontiers in Psychiatry
  3. The psychedelic-peptide paradox: a hormetic hypothesis
    Carol Sue Carter · 2025 · Comprehensive Psychoneuroendocrinology
  4. Altered effective connectivity of the default mode network in juvenile myoclonic epilepsy
    Ming Ke, Feng Wang, Guangyao Liu · 2023 · Cognitive Neurodynamics
  5. The potential risks of opening the mind’s eye with psychedelic therapies
    Roger Koenig‐Robert, Rebecca Keogh, Joel Pearson · 2025 · Cortex
  6. Psychedelics, Harm Reduction, and Life's Big Questions: Making Sense of Spirituality and Religion After the Journey
    Lisa L. Gezon, Kenton Bartlett · 2025 · Anthropology of Consciousness
  7. The transformational power of psychedelics: catalysts for creativity, consciousness, and mental health
    Xiubo Du, Jiantao Liu, Xiaohui Wang · 2025 · Molecular Psychiatry
  8. Separate or inseparable? Serotonin and dopamine system interactions may underlie the therapeutic potential of psilocybin for anorexia nervosa
    Kaspar McCoy, Felicia M. Reed, Kyna‐Anne Conn, Claire J. Foldi · 2025 · Physiology & Behavior
  9. Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence
    James J Gattuso, Bilgenur Bezcioglu, Carey Wilson, Kato Havaux, Anthony John Hannan, Thibault Renoir · 2025 · Psychedelics.
  10. Is the contemporary mental health crisis among youth due to DMN disruption?
    Henry A. Nasrallah · 2023 · Current Psychiatry
  11. Chess and the human brain- Demystifying the therapeutic value of a board game
    Saket Singh · 2023 · Journal of High School Science
  12. The Intersection of Psychedelics and Sleep: Exploring the Impacts on Sleep Architecture, Dream States, and Therapeutic Implications
    Haojiang Zhai, Hongshuang Wang, Haohong Li, Xiaohui Wang · 2025 · ACS Pharmacology & Translational Science
  13. Effects of Psilocybin on Mouse Brain Microstructure
    Paloma C. Frautschi, Ajay Paul Singh, Nicholas A. Stowe, Sean M. Grady, Zarmeen Zahid, Matthew I. Banks, John‐Paul J. Yu · 2025 · American Journal of Neuroradiology
  14. Psychedelic Therapies as Resistance to Neoliberalism: A Brazilian Schizoanalytical Perspective
    Ernesto Grillo Rabello, Fábio Hebert da Silva · 2025 · Future Humanities
  15. Natural language analysis of the structure of altered states of consciousness
    Daria Dikovskaya, Bhargav Srinivasa Desikan, Joel Frohlich, Naureen Hossain, Giani Panariello, Luke Johnson, Conor H. Murray · 2025 · Journal of Psychedelic Studies
  16. Promising experimental drugs for obsessive-compulsive personality disorder
    Donatella Marazziti, Riccardo Gurrieri, Matteo Gambini, Gerardo Russomanno, Umberto Albert · 2025 · Expert Opinion on Investigational Drugs
  17. Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care
    Kerem Kemal Soylemez, Emma Marie de Boo, Aysil Susuzlu, Joanne Marie Lusher · 2025 · Psychoactives
  18. The Role of Psychedelics in Contemporary Psychological and Interdisciplinary Inquiry
    Kerem Kemal Soylemez, Emma Marie de Boo, Aysil Susuzlu, Joanne Marie Lusher · 2025 · Journal of Personalized Medicine
  19. Meaning and Psychedelics in Palliative Care: A Narrative Review
    William B. Alexander, Eric Hansen, Brian T. Anderson, Ali John Zarrabi, Andrew H. Rogers, Gregory Loewen, Zachary R Ficcaro, Margaret H. Alexander, Dylan Schaefer, Amy Allen Case · 2025 · Journal of Pain and Symptom Management
  20. The concrit framework: Critical brain dynamics as a unifying mechanistic framework for theories of consciousness
    Inbal Algom, Oren Shriki · 2025 · Neuroscience & Biobehavioral Reviews
  21. Seeing through the static: Reduced imagery vividness in aphantasia is associated with impaired temporal lobe signal complexity
    Chanelle Noble, Natasha L. Taylor, Fraser Milton, Jonathan Fulford, Joshua B. Tan, Claire O’Callaghan, Adam Z. Zeman, James M. Shine · 2025 · Neuropsychologia
  22. Managing Psychological Challenges in the Subacute (“Afterglow”) Window of Psychedelic Drug Effects
    Ricarda Evens, Abdo Uyar, Tomislav Majić · 2025 · Current topics in behavioral neurosciences
  23. An open-label pilot study of psilocybin-assisted therapy for binge eating disorder
    Jesse Dallery, Jennifer Lynne Miller, Jeff Boissoneault, Lauren Harvey, Lindsey Ives, Alexandra W. Knerr, Shelby Blaes, Morgan N. Ransom, Melissa S. Munson, James P. Gilligan et al. · 2026 · Journal of Eating Disorders
  24. Psilocybin effects on brain functional connectivity: a systematic review of fMRI studies
    Àlvar Farré‐Colomés, Olga Rublinetska, Óscar Soto-Angona · 2026 · Discover Mental Health
  25. Brain-body integromics of the ayahuasca experience
    Francisco Madrid-Gambín, Pablo Mallaroni, Noemí Haro, Óscar J. Pozo, Natasha Leigh Mason, Johannes T. Reckweg, Lilian Kloft, Kim I. M. van Oorsouw, Stefan W. Toennes, Johannes Gerardus Ramaekers · 2026 · Biomedicine & Pharmacotherapy
  26. Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design
    Elena Koning, Cristiano Chaves, Ryan H. Kirkpatrick, Elisa Macedo Brietzke · 2024 · Journal of Eating Disorders
  27. Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’
    Sorcha O'Connor, Kate Godfrey, Sara Reed, Joseph M. Peill, Cyrus Rohani-Shukla, Mairead Healy, Trevor William Robbins, Ana Maria Frota Lisbôa Pereira de Souza, Robin J. Tyacke, Maria Papasyrou et al. · 2025 · Cureus
  28. Societal Trends and Opportunities in the Aftermath of the Nova Psychedelic Trance Rave, Through Lilla and Benjamin
    Demian Halperin, Tal Bar On, Nir Tadmor, Alma Maria Simon, Aaron D. Cherniak, Guy Simon · 2025 · Future Humanities
  29. Psychedelic Use and Behavioral Addictions
    Trey Brasher, David Rosen, M. Spinella · 2025 · Journal of Psychoactive Drugs
  30. The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?
    Trevor Ronald Norman · 2025 · Exploration of neuroscience
  31. Psilocybin for the treatment of anorexia nervosa
    Tomislav Majić, Stefan Ehrlich · 2023 · Nature Medicine
  32. Pharmakotherapie, Psychotherapie oder „Superplacebos“?
    Gerhard Gründer, Manuela Brand, Luca V. Färber, Laura Kärtner, Linda C. Kunz, Barbara Rohrmoser, Dennis Scharf, Christian Nikolaus Schmitz, Moritz Spangemacher, Lea Julia Mertens · 2024 · Die Psychotherapie
  33. Leveraging psychedelic neuroscience to boost human creativity using artificial intelligence
    Brian M. Ross · 2025 · Frontiers in Artificial Intelligence
  34. Disrupted periodic spatiotemporal pattern and dynamic reorganization of its basic states in generalized epilepsy
    Junxia Chen, Sisi Jiang, Guofeng Ye, Zhihuan Yang, Changyue Hou, Hechun Li, Haonan Pei, Roberto Rodríguez‐Labrada, Jinlei Li, Dezhong Yao et al. · 2025 · Journal of Neural Engineering
  35. Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder
    Sana Rasheed, Rida Arif, Ahmed Asad Raza, Abedin Samadi · 2025 · Annals of Medicine and Surgery
  36. Neuromodulation of excitation-inhibition balance in dementia with lewy bodies: a translational framework
    Charalampos L. Kandilakis, Panagiotis Felemegkas, Anastasios D. Papanastasiou, Ioannis Sotiropoulos, Joseph P. M. Kane, Iracema Leroi, Jon B. Toledo, Panagiotis Alexopoulos · 2025 · Journal of Neural Transmission
  37. Psilocybin-induced modulation of visual salience processing
    Stephanie L. Muller, Federico Cavanna, Laura Alethia de la Fuente, Nicolás Marcelo Bruno, Tomás Ariel D’Amelio, Carla Pallavicini, Enzo Tagliazucchi · 2025 · Neuroscience of Consciousness
  38. Evaluation of 1cp-LSD for Enhancing Welfare in Shelter Dogs: A Randomized Blind Trial with Ethological Intervention
    Elisa Hernández‐Álvarez, Cristina Canino-Quijada, Sira Roiz, Octavio P. Luzardo, Luis Alberto Henríquez‐Hernández · 2026 · Veterinary Sciences
  39. Bridging ancient substances and modern psychiatry: the role of classic psychedelics in depression treatment
    Guilherme Lodetti, Gislaine Z. Réus, Eduardo Pacheco Rico · 2026 · Neuroscience
  40. Ayahuasca enhances functional connectivity in the third visual pathway and mirror neuron networks: a crossover, multiple-dose functional MRI study
    Carla Soares, Gisela Lima, Marta Teixeira, Rebeca André, Patrícia Mendonca Rijo, Célia Cabral, Miguel S. Castelo-Branco · 2026 · Social Cognitive and Affective Neuroscience
  41. Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol Development
    Elena Koning, Susan Gamberg, Aaron R. Keshen · 2026 · Behavioral Sciences
  42. Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review
    Michel Sabé, Paul Grof, Nathan B. Sackett, Sara Tai, Pamela Kryskow, Anya K. Bershad, Douglas Turkington, Matteo Buonarroti, Marco De Pieri, Pantelis Baniotopoulos et al. · 2026 · Schizophrenia Research
  43. Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach
    Claudio Agnorelli, Joseph M. Peill, Gabriela Sawicka, Danielle L. Kurtin, Ekaterina Shatalina, Kirran Ahmad, Matthew B. Wall, Catarina Rua, Kate E.M. Godfrey, Natalie Ertl et al. · 2026 · Journal of Cerebral Blood Flow & Metabolism
  44. Classic psychedelics in obsessive–compulsive disorder: a circuit-based framework
    Saif S. Ali, Robin Lester Carhart-Harris, Karl G. Sieg · 2026 · Nature Mental Health
  45. Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action
    Jordana Kazdan, Karim Shiraz Ladha, M. Ishrat Husain · 2026 · Pharmacology Research & Perspectives
  46. Evidence in practice: implementing KAT in indigenous health services
    Jean Jacque Lovely, Hiedi Yardley, Reverdi Darda, Quintina Adolpho, Lisa Kemp, Charlene Brough, Vanessa Doore, Jennifer Kohlhammer, Andrew Charrette · 2026 · Frontiers in Psychiatry
  47. Brain-MGF: Multimodal Graph Fusion Network for EEG-FMRI Brain Connectivity Analysis Under Psilocybin
    Sin-Yee Yap, Fuad M. Noman, Junn Yong Loo, Devon Stoliker, M. Amin Khajehnejad, Raphaël C.‐W. Phan, David L. Dowe, Adeel Razi, Chee‐Ming Ting · 2026 · IEEE International Symposium on Biomedical Imaging (ISBI)
  48. Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developments
    Zuzana Postránecká, Matyáš Lucký, Viktor Mravčík, Tomáš Páleníček · 2026 · Journal of Psychedelic Studies
  49. Sex-dependent effects of psychedelics: review of evidence from rodent models
    Rafał Marecki, Wiktoria Zaniewska, Adam Hamed, Napoleon Waszkiewicz, Jacob J. Baker, Kacper Łukasiewicz · 2026 · Frontiers in Psychiatry
  50. Adolescent exposure to the psychedelic 25C-NBOMe in rats induces lasting competitive avoidance through disrupted hippocampal–prefrontal synchrony
    Zhi-Peng Yu, Zhong-Yu Zhang, Qiong Li, Y Hu, Ting Zhang, Xiaoqin Zhang, Zheng-Chun Wang, Wen-Hua Zhou, Haowei Shen · 2026 · Nature Neuroscience
  51. Exploring the benefits of altered states of consciousness and reduced experiential avoidance for mental well-being: insights from a global study on high ventilation breathwork
    Lena Erdmann, Barbara Breitenstein, Maria Badanova, Lennard Telschow, Martha Nari Havenith, Isabel Dziobek · 2026 · Frontiers in Psychology
  52. Magic Mushrooms
    Zahra Alam, Bhavana Soma · 2023 · The Meducator
  53. Introduction: philosophy and psychedelic psychiatry
    Chris Letheby, Philip Gerrans · 2024 · Oxford University Press eBooks
  54. Processing of self-related thoughts in experienced users of classic psychedelics: A source localisation EEG study
    Anastasia Ruban, Mikołaj Magnuski, Justyna Hobot, Paweł Orlowski, Aleksandra Kołodziej, Michał Bola, Aneta Brzezicka · 2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  55. An analysis of practitioners Journaled experiences of Orgasmic Meditation (OM)
    Caroline Griggs, Rachel Regan · 2025 · Sexual & Relationship Therapy
  56. Processing of self-related thoughts in experienced users of classic psychedelics and non-users: a source localisation EEG study
    Anastasia Ruban, Mikołaj Magnuski, Justyna Hobot, Paweł Orlowski, Aleksandra Kołodziej, Michał Bola, Aneta Brzezicka · 2024
  57. Not all serotonergic psychedelics are alike - they induce distinct patterns of altered metabolic activity and connectivity
    Frederik Gudmundsen, Julia Czurylo, Camilla Trang Vo, Janika Ruuska, Naja Støckel Jessen, Christina Baun, Matthias M. Herth, Vladimir Shalgunov, Patrick M. Fisher, Mikael Palner · 2024
  58. Evolving antidepressant: from SSRIs to psychedelic
    Hanyang Hong · 2023 · International Conference on Modern Medicine and Global Health (ICMMGH)
  59. The relation between naturalistic use of psychedelics and perception of emotional stimuli: An ERP study comparing non-users and experienced users of classic psychedelics
    Paweł Orlowski, Justyna Hobot, Anastasia Ruban, Jan Szczypiński, Michał Bola · 2023
  60. Therapeutic potential of N,N-dimethyltryptamine in the treatment of psychiatric and neurodegenerative disorders
    Jakub Schimmelpfennig, Kamila Jankowiak-Siuda · 2023 · Pharmacotherapy in Psychiatry and Neurology
  61. Hemispherotomy: cortical islands of deep sleep in awake humans
    Marcello Massimini, Marcello Massimini, Michele Angelo Colombo, Michele Angelo Colombo, Jacopo Favaro, Jacopo Favaro, Ezequiel Mikulan, Ezequiel Mikulan, Andrea Pigorini, Andrea Pigorini et al. · 2024 · Research Square
  62. On serotonin, psychedelics, entactogens and psychoplastogens in depression, anxiety, post-traumatic stress, and related disorders.
    Daniël Hoyer · 2024
  63. "Vine of the Soul": The Potential of Ayahuasca for Reducing Depression, Anxiety, and Stress among Ceremony Participants and the Role of Rumination
    Banan Ramarushton · 2024
  64. Psilocybin and other Psychedelics
    Alfred P. Kaye, Benjamin Kelmendi, Merangely N. Rivera, Christopher Pittenger · 2024 · Elsevier eBooks
  65. Exploring resilience with neuroimaging: Moderators of the impacts of childhood traumatic stress on fear processing.
    Karisa June Hunt · 2024
  66. Functional Near-Infrared Brain Network Characteristics Analysis in Patients with Cognitive Impairment after Stroke
    Tao Jin, Haozheng Li, Chunrong Bao, Min ZHUANG, Weiqiang CAI, Ruiping Hu, Yi WU · 2024 · Rehabilitation Medicine
  67. Mind-body medicine and altered states of consciousness in Homo
    Kazhaleh Mohammadi, Arthur Saniotis · 2024 · Anthropological Review
  68. Palliative Care and Psychedelics on a Long Strange Trip, Revisited
    Stacy M. Fischer, Beth Patterson · 2024 · Journal of Palliative Medicine
  69. Hemispherotomy: a cortical island of sleep-like activity in awake humans
    Michele Angelo Colombo, Jacopo Favaro, Ezequiel Mikulan, Andrea Pigorini, Flavia Maria Zauli, Ivana Sartori, Piergiorgio d’Orio, Laura Castana, Irene Toldo, Stefano Sartori et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  70. Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new
    Mansi Dave, Ron Shore, Tracy Cupido, Chris Haley, David Clinkard · 2025 · European Journal of Anaesthesiology
  71. Tuning into Meaning and Dropping Out of Crisis—Meaning What Exactly? Psychedelics and the Meaning Crisis
    Mark Juhan Schunemann · 2025 · Zygon®
  72. Exploring the therapeutic convergence of meditation, psychedelics, and MDMA
    Jacob T. Dines · 2025 · Journal of Psychedelic Studies
  73. Inventing Experience: Medieval, Psychedelic, and Postmodern
    Patricia Dailey · 2025 · South Atlantic Quarterly
  74. Ayahuasca Shifts Brain Dynamics Toward Higher Entropy: Persistent Elevation of Ising Temperature Correlates with Acute Subjective Effects
    Rodrigo M. Cabral-Carvalho, Fernanda Palhano-Fontes, Dráulio Barros de Araújo, João Ricardo Sato · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  75. Equipos de salud mental de enlace en el hospital oncológico: una apuesta hacia la transdisciplinariedad
    Adriana Marcela Prada, Andrés Felipe Jiménez-Mora, Juanita Rojas Restrepo · 2024 · Medicina
  76. Detecting neuroplastic effects induced by ketamine in healthy human subjects: a multimodal approach
    Claudio Agnorelli, Joseph M. Peill, Gabriela Sawicka, Danielle L. Kurtin, Ekaterina Shatalina, Kirran Ahmad, Matthew B. Wall, Catarina Rua, Kate Godfrey, Natalie Erl et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Underlying Similarities Between Psychedelic and Schizophrenia Hallucinations
    Katherine H. Frost · 2025 · American journal of student research.
  78. Psychedelics for the Treatment of Substance Use Disorders: A Narrative Review of the Literature
    Olivia Marcus, Brian R. Rush · 2025 · Substance Use &amp Addiction Journal
  79. The Analgesic and Dissociative Properties of Ketamine are Separate and Correspond to Distinct Neural Mechanisms
    Noam Goldway, Talma Hendler, Itamar Jalon, Yotam Pasternak, Roy Sar-El, Dan Mirelman, Noam Sarna, Nili Green, Yara Agbaria, Haggai Sharon · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  80. Disintegration of Default Mode: Functional MRI Insights Into N,N-Dimethyltryptamine (DMT), Consciousness, and Subcortical Connectivity.
    Amy Avakian · 2025 · Europe PMC (PubMed Central)
  81. Chronic pain is linked to a resting-state neural archetype that optimizes learning from punishments
    Francesco Scarlatti, Ludovic C. Dormegny-Jeanjean, Roman Schefzik, Tobias Banaschewski, Arun L.W. Bokde, Rüdiger Brühl, Sylvane Desrivières, Hugh Garavan, Penny Anne Gowland, Antoine Grigis et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  82. The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives
    Shadan Rahmani, Rachel Crupi, Anthony Lee Riley, Terry L. Davidson · 2025 · Pharmacology Biochemistry and Behavior
  83. Potencial terapéutico de la psilocibina en neuropsiquiatría: una revisión narrativa
    Gianfranco Faccini-Durán · 2025 · Acta neurológica colombiana
  84. Eight-week antidepressant treatment effects on connectome gradient in first-episode drug-naïve patients with major depressive disorder
    Youran Dai, Yankun Wu, Lin-Lin Zhu, Qian Yu, Ke Li, Yawei Zeng, Jitao Li, Yun‐Ai Su, Mingrui Xia, Tianmei Si · 2025 · Journal of Psychopharmacology
  85. Ethical challenges in the therapeutic application of classical psychedelics for pediatric health conditions: A comprehensive review
    Pinelopi Vlotinou, Konstantinos Christodoulou, Anna Tsiakiri, Foteini Christidi, Aspasia Serdari · 2025 · Brazilian Journal of Science
  86. Der Helioskop-Effekt
    Gregor Hasler · 2025 · Psychotherapie-Wissenschaft
  87. A Comparative Neurophenomenology of the Psychedelic State and Autism: Predictive Processing as a Unifying Lens
    William Roseby, Catriona Osborn Moar · 2025 · Psychoactives
  88. Unmixing the psychedelic connectome: Brain network traits of psilocybin
    Krishna Prasad Bhavaraju, Natasha Leigh Mason, Pablo Mallaroni, Dietmar G. Heinke, Stefan W. Toennes, Johannes Gerardus Ramaekers, Enrico Amico · 2026 · Network Neuroscience
  89. The Self-Identification Program (SIP): A Clinically Implemented Third-Wave CBT Deepening Dysfunctional Self-Identification in Mood Disorders
    Martin Leurent, Déborah Ducasse · 2025 · Medicina
  90. Positionspapier zu Psychedelika assistierter Therapie von Abhängigkeitserkrankungen der Schweizerischen Gesellschaft für Suchttherapie
    Alexander Wopfner, Thilo Beck, Louise E. Penzenstadler · 2025 · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice
  91. Ritual to Relief: Ethical Frontiers in Repurposing Psychoactive Substances
    Emma O’Leary, Seetal Dodd, Stephen M. Stahl · 2025 · Cambridge University Press eBooks
  92. Mystical experience in the Bayesian brain
    Daniel Villiger · 2025 · Phenomenology and the Cognitive Sciences
  93. Science’s “Savage Slot”: The appropriation and erasure of Indigenous science in the psychedelic renaissance
    Emilia Sanabria · 2025 · Psychedelics
  94. Therapeutic Potential of the Medicinal Mushroom in Parkinson’s Disease
    Sepehr Khosravi, Helia Alizadeh, Anahita Tarki · 2025 · Nutritional neurosciences
  95. Disrupting Circuits of the Higher Central Nervous System
    2025 · Royal Society of Chemistry eBooks
  96. Nondual Mindfulness and Psychedelic Assisted Therapy: Frameworks for Clinical Integration
    Julien Tempone-Wiltshire · 2025 · Human Arenas
  97. Consciousness
    Keith Happawana · 2025 · Springer eBooks
  98. PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION
    Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska · 2026 · International Journal of Innovative Technologies in Social Science
  99. The neurophenomenology of a self-induced transcendental visionary state: A case study
    Gabriel A. Della Bella, Agustina Velez Picatto, Dante Sebastián Galván Rial, Sebastián Cukier, Gustavo Foa Torres, Magaly Catanzariti, Diego Martin Mateos, Pedro W. Lamberti, Etzel Cardeña, Pablo Barttfeld · 2026 · NeuroImage
  100. Effects of cannabis and psychedelic use on cognitive, psychomotor, and driving performance: A review of recent literature
    Alexa Camarena-Michel, John Michael Rague · 2026 · Current Opinion in Toxicology